RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
RegeneRx Biopharmaceuticals, Inc.US flagOther OTC
0.00
USD
- -
- -
898.00Market Cap

RegeneRx Biopharmaceuticals, Inc. (RGRX) Stock Splits

Learn about RegeneRx Biopharmaceuticals, Inc.'s most recent 1-for-100 basis stock split on August 14, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about RegeneRx Biopharmaceuticals, Inc.'s most recent stock split

Split Date: 2023-08-14
Split Ratio: 1:100
Price Before Split: $0.03
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 100.00 times fewer shares (a 1:100 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of RegeneRx Biopharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-08-141:100Yes$0.03$0.00

About RegeneRx Biopharmaceuticals, Inc.

Company overview and industry information

RegeneRx Biopharmaceuticals, Inc. (RGRX) operates in the Biotechnology industry. The recent 1-for-100 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to RegeneRx Biopharmaceuticals, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.